prostaglandin E receptor 3 antagonists (Pfizer)

N/A

Report date: 2025/06/11 10:33:53
NME

Base Information

Drug Nameprostaglandin E receptor 3 antagonists (Pfizer)
Drug Alias NamePF-06747524PF-6748962PF-06748962
ClassificationSmall molecules
Mechanisms of ActionProstanoid EP3 receptor antagonists
TargetsProstanoid EP3 receptor
Therapy Area/IndicationsDiabetes Mellitus
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesPfizer Inc
China Registration ClassN/A

Develop Information

Active CompaniesPfizer Inc
Inactive CompaniesN/A
Active IndicationsDiabetes Mellitus
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A